tiprankstipranks
Procter & Gamble upgraded to Overweight from Neutral at JPMorgan
The Fly

Procter & Gamble upgraded to Overweight from Neutral at JPMorgan

JPMorgan analyst Andrea Teixeira upgraded Procter & Gamble to Overweight from Neutral with a price target of $155, up from $150. The analyst now thinks consensus estimates are low into the back end of 2023, creating a more positive setup for the shares. Investors will grow back to appreciate the earnings compounding ahead and relative resilience of names like Procter & Gamble, the analyst tells investors in a research note. The firm says capacity constraints in the company’s key divisions including fabric care and feminine care will abate this year.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on PG:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles